Cite
HARVARD Citation
Li, W. et al. (2019). Saxagliptin alters bile acid profiles and yields metabolic benefits in drug‐naïve overweight or obese type 2 diabetes patient. Journal of diabetes. 11 (12), pp. 982-992. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, W. et al. (2019). Saxagliptin alters bile acid profiles and yields metabolic benefits in drug‐naïve overweight or obese type 2 diabetes patient. Journal of diabetes. 11 (12), pp. 982-992. [Online].